Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use

Tobacco Use Clinical Trial

Official title:

Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05324813
• Other study ID #: 7420
• Status: Recruiting
• Phase: N/A
• Start date: April 2022
• Est. completion date: July 2022

Study information

• Verified date: April 2022
• Source: Advocates for Human Potential
• Contact: Michael J Sofis, PhD
• Phone: 14128678991
• Email: msofis[@]ahpnet.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overarching goal of this online study is to compare the efficacy of six (weekly) sessions of Domain-Specific Episodic Future Thinking (DS-EFT) relative an active control condition on improving the ability to value future rewards and reducing cannabis use (grams and days of use), tobacco use, and alcohol use among.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: July 2022
• Est. primary completion date: July 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• at least 18 or older

• reside in the U.S.

• report wanting to reduce cannabis use (4 or higher on scale of 1-10 with higher scores indicating greater desire to reduce use)

• report using cannabis at least 10 days in the last month

• report using cannabis at least 100 days in their lifetime

• Data quality checks passed

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Alcohol Use, Unspecified
• Marijuana Abuse
• Marijuana Dependence
• Marijuana Use
• Tobacco Use

Intervention

Behavioral:
• Domain-Specific Episodic Future Thinking
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.

Locations

Country	Name	City	State
United States	AHP Corporate Office	Sudbury	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Michael Sofis	Dartmouth College

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of cannabis use grams		1-week follow-up
Primary	Number of cannabis use days		1-week follow-up
Secondary	Number of tobacco use days		1-week follow-up
Secondary	Number of alcohol use days		1-week follow-up
Secondary	Number of tobacco use times		1-week follow-up
Secondary	Number of alcoholic drinks		1-week follow-up
Secondary	Rate of delay discounting	5-trial adjusting delay discounting task	1-week follow-up